Contineum Therapeutics
CTNM
#8483
Rank
NZ$0.26 B
Marketcap
$10.25
Share price
-5.92%
Change (1 day)
-59.97%
Change (1 year)

Earnings for Contineum Therapeutics (CTNM)

Earnings in 2024 (TTM): -NZ$70.9 Million

According to Contineum Therapeutics's latest financial reports the company's current earnings are N/A. a decrease over its 2023 earnings that were of NZ$41.17 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Contineum Therapeutics from 2023 to 2024

Annual earnings

Year Earnings Change
2024 -NZ$75.11 Million-282.38%
2023 NZ$41.17 M